Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥1,500 32 38 32 38 O
cells 39 44 39 44 I-lower_bound
/ 44 45 44 45 I-lower_bound
mm3 45 48 45 48 I-lower_bound

Active 0 6 49 55 B-chronic_disease
, 6 7 55 56 I-chronic_disease
uncontrolled 8 20 57 69 I-chronic_disease
bacterial 21 30 70 79 I-chronic_disease
, 30 31 79 80 I-chronic_disease
viral 32 37 81 86 I-chronic_disease
, 37 38 86 87 I-chronic_disease
or 39 41 88 90 I-chronic_disease
fungal 42 48 91 97 I-chronic_disease
infection 49 58 98 107 I-chronic_disease
requiring 59 68 108 117 O
systemic 69 77 118 126 B-treatment
therapy 78 85 127 134 I-treatment

Age 0 3 135 138 B-age
≥18 4 7 139 142 O
years 8 13 143 148 I-lower_bound

Aspartate 0 9 149 158 B-clinical_variable
aminotransferase 10 26 159 175 I-clinical_variable

For 0 3 176 179 O
men 4 7 180 183 B-gender
and 8 11 184 187 O
women 12 17 188 193 B-gender
of 18 20 194 196 O
reproductive 21 33 197 209 O
potential 34 43 210 219 O
, 43 44 219 220 O
agreement 45 54 221 230 B-contraception_consent
to 55 57 231 233 I-contraception_consent
use 58 61 234 237 I-contraception_consent
an 62 64 238 240 I-contraception_consent
effective 65 74 241 250 I-contraception_consent
contraceptive 75 88 251 264 I-contraception_consent
method 89 95 265 271 I-contraception_consent
from 96 100 272 276 O
the 101 104 277 280 O
time 105 109 281 285 O
of 110 112 286 288 O
screening 113 122 289 298 O
and 123 126 299 302 O
throughout 127 137 303 313 O
their 138 143 314 319 O
time 144 148 320 324 O
on 149 151 325 327 O
study 152 157 328 333 O

For 0 3 334 337 O
patients 4 12 338 346 O
with 13 17 347 351 O
metastatic 18 28 352 362 B-cancer
disease 29 36 363 370 I-cancer
, 36 37 370 371 O
prior 38 43 372 377 B-treatment
treatment 44 53 378 387 I-treatment
for 54 57 388 391 O
non 58 61 392 395 B-cancer
- 61 62 395 396 I-cancer
metastatic 62 72 396 406 I-cancer
disease 73 80 407 414 I-cancer
with 81 85 415 419 O
5 86 87 420 421 B-treatment
- 87 88 421 422 I-treatment
FU 88 90 422 424 I-treatment
or 91 93 425 427 O
gemictabine 94 105 428 439 B-treatment
administered 106 118 440 452 O
as 119 121 453 455 O
radiation 122 131 456 465 B-treatment
sensitizer 132 142 466 476 I-treatment
, 142 143 476 477 O
or 144 146 478 480 O
as 147 149 481 483 O
a 150 151 484 485 O
cytotoxic 152 161 486 495 B-treatment
therapy 162 169 496 503 I-treatment
, 169 170 503 504 O
in 171 173 505 507 O
the 174 177 508 511 O
adjuvant 178 186 512 520 O
setting 187 194 521 528 O

Hemoglobin 0 10 529 539 B-clinical_variable
≥9 11 13 540 542 O
g 14 15 543 544 I-lower_bound
/ 15 16 544 545 I-lower_bound
dL 16 18 545 547 I-lower_bound

Histologically 0 14 548 562 O
confirmed 15 24 563 572 O
locally 25 32 573 580 O
advanced 33 41 581 589 O
unresectable 42 54 590 602 O
( 55 56 603 604 B-cancer
Stage 56 61 604 609 I-cancer
III 62 65 610 613 I-cancer
) 65 66 613 614 I-cancer
or 67 69 615 617 I-cancer
Stage 70 75 618 623 I-cancer
IV 76 78 624 626 I-cancer
PDAC 79 83 627 631 I-cancer

Intolerance 0 11 632 643 O
of 12 14 644 646 O
dexamethasone 15 28 647 660 B-allergy_name

Karnofsky 0 9 661 670 B-clinical_variable
Performance 10 21 671 682 I-clinical_variable
Status 22 28 683 689 I-clinical_variable
≥70 29 32 690 693 O
% 32 33 693 694 I-lower_bound

Known 0 5 695 700 O
, 5 6 700 701 O
clinically 7 17 702 712 O
significant 18 29 713 724 O
carotid 30 37 725 732 B-chronic_disease
artery 38 44 733 739 I-chronic_disease
disease 45 52 740 747 I-chronic_disease

Known 0 5 748 753 O
, 5 6 753 754 O
increased 7 16 755 764 O
risk 17 21 765 769 O
of 22 24 770 772 O
bleeding 25 33 773 781 B-chronic_disease

Measurable 0 10 782 792 B-chronic_disease
or 11 13 793 795 I-chronic_disease
evaluable 14 23 796 805 I-chronic_disease
disease 24 31 806 813 I-chronic_disease
on 32 34 814 816 O
computed 35 43 817 825 B-treatment
tomography 44 54 826 836 I-treatment
( 55 56 837 838 I-treatment
CT 56 58 838 840 I-treatment
) 58 59 840 841 I-treatment

New 0 3 842 845 B-clinical_variable
York 4 8 846 850 I-clinical_variable
Heart 9 14 851 856 I-clinical_variable
Association 15 26 857 868 I-clinical_variable
Class 27 32 869 874 I-clinical_variable
III 33 36 875 878 B-lower_bound
or 37 39 879 881 O
IV 40 42 882 884 B-upper_bound
cardiac 43 50 885 892 B-chronic_disease
disease 51 58 893 900 I-chronic_disease
or 59 61 901 903 O
myocardial 62 72 904 914 B-chronic_disease
infarction 73 83 915 925 I-chronic_disease
within 84 90 926 932 O
the 91 94 933 936 O
past 95 99 937 941 B-upper_bound
12 100 102 942 944 I-upper_bound
months 103 109 945 951 I-upper_bound

Partial 0 7 952 959 B-clinical_variable
thromboplastin 8 22 960 974 I-clinical_variable
time 23 27 975 979 I-clinical_variable
( 28 29 980 981 I-clinical_variable
PTT 29 32 981 984 I-clinical_variable
) 32 33 984 985 I-clinical_variable
within 34 40 986 992 I-clinical_variable
normal 41 47 993 999 I-clinical_variable
limits 48 54 1000 1006 I-clinical_variable
( 55 56 1007 1008 O
±15 56 59 1008 1011 O
% 59 60 1011 1012 I-lower_bound
) 60 61 1012 1013 O

Patients 0 8 1014 1022 O
with 9 13 1023 1027 O
current 14 21 1028 1035 O
use 22 25 1036 1039 O
of 26 28 1040 1042 O
megestrol 29 38 1043 1052 B-treatment
acetate 39 46 1053 1060 I-treatment
( 47 48 1061 1062 O
use 48 51 1062 1065 O
with 52 56 1066 1070 O
10 57 59 1071 1073 B-upper_bound
days 60 64 1074 1078 I-upper_bound
of 65 67 1079 1081 O
Day 68 71 1082 1085 B-lower_bound
1 72 73 1086 1087 I-lower_bound
) 73 74 1087 1088 O

Platelet 0 8 1089 1097 B-clinical_variable
count 9 14 1098 1103 I-clinical_variable
≥100,000 15 23 1104 1112 O
plt 24 27 1113 1116 I-lower_bound
/ 27 28 1116 1117 I-lower_bound
mm3 28 31 1117 1120 I-lower_bound

Prothrombin 0 11 1121 1132 B-clinical_variable
time 12 16 1133 1137 I-clinical_variable
( 17 18 1138 1139 I-clinical_variable
PT)/international 18 35 1139 1156 I-clinical_variable
normalized 36 46 1157 1167 I-clinical_variable
ratio 47 52 1168 1173 I-clinical_variable
( 53 54 1174 1175 I-clinical_variable
INR 54 57 1175 1178 I-clinical_variable
) 57 58 1178 1179 I-clinical_variable
within 59 65 1180 1186 O
normal 66 72 1187 1193 O
limits 73 79 1194 1200 O
( 80 81 1201 1202 O
±15 81 84 1202 1205 B-upper_bound
% 84 85 1205 1206 I-upper_bound
) 85 86 1206 1207 O
or 87 89 1208 1210 O
within 90 96 1211 1217 O
therapeutic 97 108 1218 1229 O
range 109 114 1230 1235 O
if 115 117 1236 1238 O
on 118 120 1239 1241 O
warfarin 121 129 1242 1250 B-treatment

Screening 0 9 1251 1260 O
clinical 10 18 1261 1269 O
laboratory 19 29 1270 1280 O
values 30 36 1281 1287 O
as 37 39 1288 1290 O
follows 40 47 1291 1298 O
, 47 48 1298 1299 O
performed 49 58 1300 1309 O
within 59 65 1310 1316 O
14 66 68 1317 1319 B-upper_bound
days 69 73 1320 1324 I-upper_bound
prior 74 79 1325 1330 I-upper_bound
to 80 82 1331 1333 O
day 83 86 1334 1337 O
1 87 88 1338 1339 O

Total 0 5 1340 1345 O
bilirubin 6 15 1346 1355 B-clinical_variable
≤1.5 16 20 1356 1360 O
times 21 26 1361 1366 I-upper_bound
upper 27 32 1367 1372 I-upper_bound
limit 33 38 1373 1378 I-upper_bound
of 39 41 1379 1381 I-upper_bound
normal 42 48 1382 1388 I-upper_bound
( 49 50 1389 1390 I-upper_bound
ULN 50 53 1390 1393 I-upper_bound
) 53 54 1393 1394 I-upper_bound

Women 0 5 1395 1400 B-gender
currently 6 15 1401 1410 B-pregnancy
pregnant 16 24 1411 1419 I-pregnancy

[ 0 1 1420 1421 O
ALT 1 4 1421 1424 O
] 4 5 1424 1425 O
; 5 6 1425 1426 O
serum 7 12 1427 1432 B-clinical_variable
glutamic 13 21 1433 1441 I-clinical_variable
pyruvate 22 30 1442 1450 I-clinical_variable
transaminase 31 43 1451 1463 I-clinical_variable
[ 44 45 1464 1465 I-clinical_variable
SGPT 45 49 1465 1469 I-clinical_variable
] 49 50 1469 1470 I-clinical_variable
) 50 51 1470 1471 O
≤2.5 52 56 1472 1476 O
times 57 62 1477 1482 I-upper_bound
ULN 63 66 1483 1486 I-upper_bound

brain 0 5 1487 1492 B-cancer
metastases 6 16 1493 1503 I-cancer

calculated 0 10 1504 1514 O
creatinine 11 21 1515 1525 B-clinical_variable
clearance 22 31 1526 1535 I-clinical_variable
≥60 32 35 1536 1539 O
mL 36 38 1540 1542 I-lower_bound
/ 38 39 1542 1543 I-lower_bound
min 39 42 1543 1546 I-lower_bound

metabolic 0 9 1547 1556 B-chronic_disease
dysfunction 10 21 1557 1568 I-chronic_disease

no 0 2 1569 1571 O
previous 3 11 1572 1580 O
radiotherapy 12 24 1581 1593 B-treatment
, 24 25 1593 1594 O
surgery 26 33 1595 1602 B-treatment
, 33 34 1602 1603 O
chemotherapy 35 47 1604 1616 B-treatment
, 47 48 1616 1617 O
or 49 51 1618 1620 O
investigational 52 67 1621 1636 B-treatment
therapy 68 75 1637 1644 I-treatment
for 76 79 1645 1648 O
the 80 83 1649 1652 O
treatment 84 93 1653 1662 O
of 94 96 1663 1665 O
PDAC 97 101 1666 1670 O

